Lance Kugler, M.D. at Kugler Vision in Omaha, Neb., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

“We work with cataract patients each day and many ask if their surgery will help them regain not only their distance vision, but also their intermediate and near vision,” Dr. Kugler said. “We look forward to evaluating the IC-8 lens and its ability to provide cataract patients with an uninterrupted range of vision.”

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops, leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.

Dr. Kugler will be one of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

Kugler Vision is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

  • At least 22 years of age.
  • Have cataracts in both eyes.
  • Are available, willing and able to participate in examinations and all follow-up study visits and appointments.